Adaptive Biotechnologies Corp. (ADPT)
16.24
-0.18
(-1.10%)
USD |
NASDAQ |
Dec 31, 16:00
16.00
-0.24
(-1.48%)
After-Hours: 20:00
Adaptive Biotechnologies Cash from Investing (Quarterly): 17.28M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Zymeworks, Inc. | 0.31M |
| Cue Biopharma, Inc. | -6.768M |
| Recursion Pharmaceuticals, Inc. | -2.549M |
| Arcellx, Inc. | -20.03M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.127M |
| Cash from Financing (Quarterly) | 1.684M |
| Free Cash Flow | -62.94M |
| Free Cash Flow Per Share (Quarterly) | -0.0462 |
| Free Cash Flow to Equity (Quarterly) | -3.242M |
| Free Cash Flow to Firm (Quarterly) | -4.565M |
| Free Cash Flow Yield | -2.53% |